Filing Details

Accession Number:
0000950170-24-041024
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-03 16:01:07
Reporting Period:
2024-04-01
Accepted Time:
2024-04-03 16:01:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1423327 Rohan Palekar C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-01 25,000 $1.93 511,889 No 4 M Direct
Common Stock Disposition 2024-04-01 52,718 $10.91 459,171 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-04-01 25,000 $0.00 25,000 $1.93
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
120,231 2028-11-09 No 4 M Direct
Footnotes
  1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
  2. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.65 to $11.54. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  3. This option is vested in full.